HC Wainwright & Co. Reiterates Buy on Precigen, Maintains $6 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterated a Buy rating on Precigen (NASDAQ:PGEN) and maintained a $6 price target.

March 20, 2024 | 10:52 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. reaffirmed a Buy rating on Precigen, with a $6 price target, indicating a positive outlook on the stock.
The reiteration of a Buy rating and maintenance of a $6 price target by a reputable analyst firm like HC Wainwright & Co. suggests a strong belief in Precigen's potential for growth. This endorsement is likely to instill confidence among investors, potentially driving up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100